Literature DB >> 17911352

Benefits of lifestyle modification in NAFLD.

Stephen A Harrison1, Christopher Paul Day.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17911352      PMCID： PMC2095707          DOI： 10.1136/gut.2006.112094

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  87 in total

Review 1.  From fat to inflammation.

Authors:  Christopher Paul Day
Journal:  Gastroenterology       Date:  2006-01       Impact factor: 22.682

2.  Sedentary lifestyle and antecedents of cardiovascular disease in young adults.

Authors:  Jonathan M McGavock; Todd J Anderson; Richard Z Lewanczuk
Journal:  Am J Hypertens       Date:  2006-07       Impact factor: 2.689

3.  The effect of a low-carbohydrate, ketogenic diet on nonalcoholic fatty liver disease: a pilot study.

Authors:  David Tendler; Sauyu Lin; William S Yancy; John Mavropoulos; Pam Sylvestre; Don C Rockey; Eric C Westman
Journal:  Dig Dis Sci       Date:  2007-01-12       Impact factor: 3.199

4.  Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD.

Authors:  Hellan Kang; Joel K Greenson; Jason T Omo; Cewin Chao; Debra Peterman; Lilian Anderson; Laura Foess-Wood; Mary A Sherbondy; Hari S Conjeevaram
Journal:  Am J Gastroenterol       Date:  2006-10       Impact factor: 10.864

5.  Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery.

Authors:  Kevin B Barker; Nicole A Palekar; Steven P Bowers; Joel E Goldberg; Joseph P Pulcini; Stephen A Harrison
Journal:  Am J Gastroenterol       Date:  2006-02       Impact factor: 10.864

6.  Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group.

Authors:  X R Pan; W Y Yang; G W Li; J Liu
Journal:  Diabetes Care       Date:  1997-11       Impact factor: 19.112

7.  Impact of weight loss on the metabolic syndrome.

Authors:  S Phelan; T A Wadden; R I Berkowitz; D B Sarwer; L G Womble; R K Cato; R Rothman
Journal:  Int J Obes (Lond)       Date:  2007-03-13       Impact factor: 5.095

8.  Dietary fat content modifies liver fat in overweight nondiabetic subjects.

Authors:  Jukka Westerbacka; Katriina Lammi; Anna-Maija Häkkinen; Aila Rissanen; Irma Salminen; Antti Aro; Hannele Yki-Järvinen
Journal:  J Clin Endocrinol Metab       Date:  2005-03-01       Impact factor: 5.958

9.  Orlistat in the treatment of NASH: a case series.

Authors:  Stephen A Harrison; Sanjay Ramrakhiani; Elizabeth M Brunt; Maan A Anbari; Cherise Cortese; Bruce R Bacon
Journal:  Am J Gastroenterol       Date:  2003-04       Impact factor: 10.864

10.  Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial.

Authors:  Christopher D Gardner; Alexandre Kiazand; Sofiya Alhassan; Soowon Kim; Randall S Stafford; Raymond R Balise; Helena C Kraemer; Abby C King
Journal:  JAMA       Date:  2007-03-07       Impact factor: 56.272
View more
  56 in total

1.  Lifestyle Modification through Dietary Intervention: Health Promotion of Patients with Non-Alcoholic Fatty Liver Disease.

Authors:  Seyed Rafie Arefhosseini; Mehrangiz Ebrahimi-Mameghani; Alireza Farsad Naeimi; Manoochehr Khoshbaten; Javad Rashid
Journal:  Health Promot Perspect       Date:  2011-12-20

2.  Treatment options for nonalcoholic Fatty liver disease.

Authors:  Shivakumar Chitturi
Journal:  Therap Adv Gastroenterol       Date:  2008-11       Impact factor: 4.409

3.  Current status of therapy in nonalcoholic Fatty liver disease.

Authors:  Scott McNear; Stephen A Harrison
Journal:  Therap Adv Gastroenterol       Date:  2009-01       Impact factor: 4.409

Review 4.  Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms.

Authors:  Chiara Saponaro; Melania Gaggini; Amalia Gastaldelli
Journal:  Curr Diab Rep       Date:  2015-06       Impact factor: 4.810

Review 5.  Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries.

Authors:  Hilmar K Lückhoff; Frederik C Kruger; Maritha J Kotze
Journal:  World J Hepatol       Date:  2015-05-28

Review 6.  Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology.

Authors:  Guy Bower; Tania Toma; Leanne Harling; Long R Jiao; Evangelos Efthimiou; Ara Darzi; Thanos Athanasiou; Hutan Ashrafian
Journal:  Obes Surg       Date:  2015-12       Impact factor: 4.129

7.  Exercise and physical activity in cirrhosis: opportunities or perils.

Authors:  Annette Bellar; Nicole Welch; Srinivasan Dasarathy
Journal:  J Appl Physiol (1985)       Date:  2020-04-02

8.  Improved hepatic lipid composition following short-term exercise in nonalcoholic fatty liver disease.

Authors:  Jacob M Haus; Thomas P J Solomon; Karen R Kelly; Ciaran E Fealy; Emily L Kullman; Amanda R Scelsi; Lan Lu; Mangesh R Pagadala; Arthur J McCullough; Chris A Flask; John P Kirwan
Journal:  J Clin Endocrinol Metab       Date:  2013-04-24       Impact factor: 5.958

9.  Is there an effective therapy available for non-alcoholic fatty liver disease?

Authors:  Vittorio Di Maso; Stefano Bellentani
Journal:  F1000 Med Rep       Date:  2009-06-29

Review 10.  Hypertension and hepatic steatosis.

Authors:  Matthew J Brookes; Tariq H Iqbal; Brian T Cooper
Journal:  Curr Hypertens Rep       Date:  2008-06       Impact factor: 5.369
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.